Evidence map›Paper›PMID 35915374›Full record

ArticleJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract2022

The Application of Two-Stage Operation for High-Risk Patients with Oesophageal Cancer Following Gastrectomy.

Gao-Li Liu, Xin Wang, Hai-Feng Hu, Zhi-Hao Nie, Wei Ming, Xing-Lin Long, Wen-Han Zhang, Xing-Hua Zhang, Jie Huang, Wan-Li Jiang and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Gao-Li Liu *Department of Thoracic Surgery, Renmin Hospital of Wuhan University, Hubei Province, Jiefang Road 238, Wuhan City, 430060, People's Republic of China.
Xin Wang *Department of Thoracic Surgery, Nanyang Centre Hospital, Gongnong Road 312, Henan Province, 473000, Nanyang City, People's Republic of China.
Hai-Feng Hu *Department of Thoracic Surgery, Renmin Hospital of Wuhan University, Hubei Province, Jiefang Road 238, Wuhan City, 430060, People's Republic of China.
Zhi-Hao NieDepartment of Thoracic Surgery, Renmin Hospital of Wuhan University, Hubei Province, Jiefang Road 238, Wuhan City, 430060, People's Republic of China.
Wei MingDepartment of Thoracic Surgery, Yangxin County, Yangxin People's Hospital, Hubei Province, Ruxue Road 81, Huangshi City, 435200, People's Republic of China.
Xing-Lin LongDepartment of Thoracic Surgery, Renmin Hospital of Wuhan University, Hubei Province, Jiefang Road 238, Wuhan City, 430060, People's Republic of China.
Wen-Han ZhangDepartment of Thoracic Surgery, Renmin Hospital of Wuhan University, Hubei Province, Jiefang Road 238, Wuhan City, 430060, People's Republic of China.
Xing-Hua ZhangDepartment of Thoracic Surgery, Renmin Hospital of Wuhan University, Hubei Province, Jiefang Road 238, Wuhan City, 430060, People's Republic of China.
Jie HuangDepartment of Thoracic Surgery, Renmin Hospital of Wuhan University, Hubei Province, Jiefang Road 238, Wuhan City, 430060, People's Republic of China.
Wan-Li JiangDepartment of Thoracic Surgery, Renmin Hospital of Wuhan University, Hubei Province, Jiefang Road 238, Wuhan City, 430060, People's Republic of China. 418319069@qq.com.
Song-Ping XieDepartment of Thoracic Surgery, Renmin Hospital of Wuhan University, Hubei Province, Jiefang Road 238, Wuhan City, 430060, People's Republic of China. songping0428@126.com.
Wuhan University · CNRenmin Hospital of Wuhan University · CNNanyang Institute of Technology · CNPeople's Hospital of Yangzhong · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOesophageal replacement by colonic interposition remains a major challenge due to its complexity and high incidence of complications; here we applied the two-stage operation strategy to oesophageal replacement by colonic interposition in high-risk oesophageal cancer patients following gastrectomy.

methodsWe performed a retrospective analysis on the data of patients with a history of distal gastrectomy who underwent one-stage and two-stage oesophageal replacement by colonic interposition from February 2012 to February 2020, and explored the relationship between the staging strategy and postoperative outcomes.

resultsThe clinical data of 93 patients were collected and analysed. There were no significant differences in the patients' characteristics between the two groups (all p > 0.05), except for comorbidities and Charlson Comorbidity Index (all p < 0.05). The Clavien-Dindo score between the two groups was also not significantly different (p > 0.05). The logistic regression models revealed that patients who had received preoperative therapy had a higher Clavien-Dindo score (p < 0.05), but the stage strategy did not (p > 0.05).

conclusionsThe two-stage operation is feasible in high-risk patients who need to undergo colonic interposition for oesophageal replacement. At the same time, it lowers the technical threshold of colonic interposition for oesophageal replacement, increasing this surgical technique's acceptability.

Indexed as

Esophageal NeoplasmsStomach NeoplasmsGastrectomyHumansPostoperative ComplicationsRetrospective StudiesColonic interposition for oesophageal replacementHigh-riskTwo-stage operation

Identifiers

PMID35915374
OpenAlexW4289341890

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.